Also published in GlobeNewswire:
NACD Directorship 100 Forum Focused on Reinvigorating America
x hide permanently

Cerecor Appoints Keith Schmidt to its Board of Directors

GlobeNewswire

(GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare and orphan diseases in pediatrics and neurology, today announced the appointment of Keith Schmidt to its Board of Directors effective immediately.  Mr. Schmidt joins the Cerecor Board as a member of the Audit Committee, the Compensation Committee, and an independent director serving a term ending at the 2019 Annual Meeting...

Mentions: Audit Committee Independent Director Annual Meeting